Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains

Vaccine

Volumn 29, Issue 14, 2011, Pages 2590-2600

  Rauw, F ^a   Palya, V ^b   Van Borm, S ^a   Welby, S ^a   Tatar Kis, T ^b   Gardin, Y ^c   Dorsey, K Moore ^d   Aly, M M ^e   Hassan, M K ^e   Soliman, M A ^e   Lambrecht, B ^a   van den Berg, T ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b Ceva Phylaxia Veterinary Biologicals Co Ltd   (Hungary)

^c CEVA SANTÉ ANIMALE   (France)

^d Biomune Company   (United States)

^e ANIMAL HEALTH RESEARCH INSTITUTE   (Egypt)

Author keywords

Chicken; Egypt; H5N1; Influenza; Vaccination

Indexed keywords

AVIAN INFLUENZA VACCINE; HVT H5 VACCINE; INACTIVATED VACCINE; INFLUENZA VIRUS A H5N2 VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CHICKEN; CLADISTICS; DRUG EFFICACY; GENE EXPRESSION; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; MORBIDITY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; DRUG CARRIERS; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HERPESVIRUS 1, MELEAGRID; IMMUNIZATION, SECONDARY; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; VACCINATION; VACCINES, INACTIVATED; VACCINES, SYNTHETIC;

EID: 79952247186     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.048     Document Type: Article

References (46)

1. Aly M.M., Arafa A., Hassan M.K. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Diseases 2008, 52:269-277.
2. Swayne D.E. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Annals of the New York Academy of Sciences 2006, 1081:174-181.
3. Kapczynski D.R., Swayne D.E. Influenza vaccines for avian species. Current Topics in Microbiology and Immunology 2009, 333:133-152.
4. Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., et al. Avian influenza vaccination in Egypt: limitations of the current strategy. Journal of Molecular and Genetic Medicine 2009, 3(2):198-204.
5. Peyre M., Fusheng G., Desvaux S., Roger F. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiology and Infection 2009, 137:1-21.
6. Swayne D.E., Lee C.W., Spackman E. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathology 2006, 35(2):141-146.
7. Abdel-Moneim A.S., Shany S.A.S., Fereidouni S.R., Eid B.T.M., El-Kady M.F., Starick E., et al. Sequence diversity of the haemagglutinin open reading frame of recent highly pathogenic avian influenza H5N1 isolates from Egypt. Archives of Virology 2009, 154:1559-1562.
8. Cattoli G., Monne I., Fusaro A., Joannis T.M., Lombin L.H., Aly M.M., et al. Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS One 2009, 4(3):e4842.
9. Balish A.L., Davis C.T., Saad M.D., El-Sayed N., Esmat H., Tjaden J.A., et al. Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt. Avian Diseases 2010, 54(Suppl. 1):329-334.
10. Swayne D.S., Kapczynski D.R. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunological Reviews 2008, 225(1):314-331.
11. Salzberg L., Kingsford C., Cattoli G., Spiro D.J., Janies D.A., Aly M.M., et al. Genome analysis linking recent European and African influenza (H5N1) viruses. Emerging Infectious Diseases 2007, 13(5):713-716.
12. World Health Organization/OIE/FAO H5N1 Evolution Working Group. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza and other respiratory viruses 2009;3:59-62.
13. Sondermeijer P.J.A., Claessens J.A.J., Jenniskens P.E., Mockett A.P.A., Thijssen R.A.J., Willemse M.J., et al. Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine 1993, 11(3):349-358.
14. Bublot M., Sharma J. Vaccination against Marek's disease. Marek's Disease, An Evolving Problem 2004, 168-185. Elsevier Academic Press, San Diego, USA. F. Davison, V. Nair (Eds.).
15. Heckert R.A., Riva J., Cook S., McMillen J., Schwartz R.D. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Diseases 1996, 40(4):770-777.
16. Reddy S.K., Sharma J.M., Ahmad J., Reddy D.N., McMillen J.K., Cook S.M., et al. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 1996, 14(6):469-477.
17. Darteil R., Bublot M., Laplace E., Bouquet J.F., Audonnet J.C., Rivière M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 1995, 211(2):481-490.
18. Morgan R.W., Gelb J.J., Schreurs C.S., Lutticken D., Rosenberger J.K., Sondermeijer P.J.A. Protection of chickens from Newcastle and Marek'diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Diseases 1992, 36:858-870.
19. Morgan R.W., Gelb J.J., Pope C.R., Sondermeijer P.J.A. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Diseases 1993, 37(4):1032-1040.
20. Perozo F., Villegas P., Fernandez R., Cruz J., Pritchard N. Efficacy of single dose recombinant herpesvirus of turkey infectious bursal disease virus (IBDV) vaccination against a variant IBDV strain. Avian Diseases 2009, 53:624-628.
21. Rauw F., Gardin Y., Palya V., Anbari S., Lemaire S., Boschmans M., et al. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 2010, 28:823-833.
22. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., et al. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. Journal of Virology 2002, 76(11):5637-5645.
23. De Vriese J, Steensels M., Palya V., Gardin Y., Dorsey Moore K., Lambrecht B., et al. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Diseases 2010, 54(Suppl. 1):246-252.
24. Terregino C., Toffan A., Cilloni F., Monne I., Bertoli E., Castellanos L., et al. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests. Avian Pathology 2010, 39(3):215-222.
25. Steensels M., Van Borm S., Lambrecht B., De Vriese J., Le Gros F.X., Bublot M., et al. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Diseases 2007, 51:325-331.
26. Van Borm S., Steensels M., Ferreira H.L., Boschmans M., De Vriese J., Lambrecht B., et al. A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification. Avian Diseases 2007, 51:213-220.
27. Steensels M., Bublot M., Van Borm S., De Vriese J., Lambrecht B., Richard-Mazet A., et al. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 2009, 27(5):646-654.
28. Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Micorbiology 2002, 40(9):3256-3260.
29. Rauw F., Gardin Y., Palya V., Van Borm S., Gonze M., Lemaire S., et al. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle Disease vaccines. Vaccine 2009, 27:3631-3642.
30. van der Goot J.A, De Jong M.C.M., Koch G., Van Boven M. Comparison of the transmission characteristics of low and high pathogenicity avian influenza A virus (H5N2). Epidemiology and Infection 2003, 131:1003-1013.
31. Velthuis A.G.J., Bouma A., Katsma W.E.A., Nodelijk G., De Jong M.C. Design and analysis of small-scale transmission experiments with animals. Epidemiology and Infection 2007, 135:202-217.
32. Duvvuri V.R., Duvvuri B., Cuff W.R., Wu G.E., Wu J. Role of positive selection pressure on the evolution of H5N1 hemagglutinin. Genomics Proteomics Bioinformatics 2009, 7(1-2):47-56.
33. Kim J.K., Kayali G., Walker D., Forrest H.L., Ellebedy A.H., Griffin Y.S., et al. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(24):11044-11049.
34. Spackman E., Senne D.A., Bulaga L.L., Myers T.J., Perdue M.L., Garber L.P., et al. Development of real-time RT-PCR for the detection of avian Influenza virus. Avian Diseases 2003, 27(3):1079-1082.
35. Webster R.G., Peiris M., Chen H., Guan Y. H5N1 outbreak and enzootic influenza. Emerging Infectious Diseases 2006, 12(1):3-8.
36. Heller E.D., Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathology 1987, 16(1):51-60.
37. Bermudez A.J., Stewart-Brown B. Disease prevention and diagnostic. Disease of Poultry 2003, 17-55. Iowas State University Press. Y.M. Saif (Ed.).
38. Marangon S., Busani L. The use of vaccination in poultry production. Revue Scientifique et Technique - Office International des Epizooties 2006, 26(1):265-274.
39. Swayne D.E., Halvorson D.A. Influenza. Poultry Diseases 2003, vol. 11:135-160. Iowas State University Press.
40. Swayne D.E., Suarez D.L., Schultz-Cherry S., Tumpey T.M., King D.J., Nakaya T., et al. Recombinant paramyxovirus type 1 avian influenza H7 virus as a vaccine for protection of chickens against Influenza and Newcastle disease. Avian Diseases 2003, 47:1047-1050.
41. Fouchier R.A.M., Smith D.J. Use of antigenic cartography in vaccine seed strain selection. Avian Diseases 2010, 54(Suppl. 1):220-223.
42. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection. Emerging Infectious Diseases 2006, 12(1):48-54.
43. Lambrecht B., Gonze M., Meulemans G., van den Berg T. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation. Avian Pathology 2004, 33:343-350.
44. Rauw F., Gardin Y., Palya V., Van Borm S., Gonze M., Lemaire S.ET-AL> The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chicken's vaccination with live Newcastle disease vaccine. Veterinary Immunology and Immunopathology 2010, 134:249-258.
45. Swayne D.E., Perdue M.L., Beck J.R., Garcia M., Suarez D.L. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in filed viruses over multiple years. Veterinary Microbiology 2000, 74(1-2):165-172.
46. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian Influenza virus. Journal of Virology 2004, 78(15):8372-8381.